𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Circulating levels of free insulin-like growth factors in obese subjects: the impact of Type 2 diabetes

✍ Scribed by J. Frystyk; C. Skjærbæk; E. Vestbo; S. Fisker; H. Ørskov

Publisher
John Wiley and Sons
Year
1999
Tongue
English
Weight
146 KB
Volume
15
Category
Article
ISSN
1520-7552

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The role of insulin-like growth factor-I
The role of insulin-like growth factor-I and its binding proteins in glucose homeostasis and type 2 diabetes
✍ Swapnil N. Rajpathak; Marc J. Gunter; Judith Wylie-Rosett; Gloria Y. F. Ho; Robe 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 186 KB

This review addresses the possible role of the insulin-like growth factor (IGF)axis in normal glucose homoeostasis and in the etiopathogenesis of type 2 diabetes. IGF-I, a peptide hormone, shares amino acid sequence homology with insulin and has insulin-like activity; most notably, the promotion of

Serum levels of insulin-like growth fact
Serum levels of insulin-like growth factor 1 in subjects with osteoarthritis of the knee. Data from the baltimore longitudinal study of aging
✍ Marc C. Hochberg; Margaret Lethbridge-Cejku; William W. Scott Jr.; Ralph Reichle 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 383 KB 👁 2 views

To examine the relationship between serum levels of insulin-like growth factor 1 (IGF-1) and osteoarthritis (OA) of the knee. Methods. Serum IGF-1 levels were compared in 162 male and 101 female subjects age 220 stratified by presence of radiographic changes of OA of the knee. Results. Mean serum

Uptake of circulating insulin-like growt
Uptake of circulating insulin-like growth factor-I into the cerebrospinal fluid of normal and diabetic rats and normalization of IGF-II mRNA content in diabetic rat brain
✍ C.S. Armstrong; L. Wuarin; D.N. Ishii 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 192 KB 👁 2 views

Brain injury has been prevented recently by systemic administration of human insulin-like growth factor-I (hIGF-I). It is widely believed that protein neurotrophic factors do not enter the brain from blood, and the mechanism by which circulating hIGF-I may be neuroprotective is uncertain. This inves